Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

118.61
+3.322.88%
Post-market: 118.610.00000.00%19:14 EDT
Volume:1.21M
Turnover:142.19M
Market Cap:17.36B
PE:10.61
High:118.77
Open:115.02
Low:114.66
Close:115.29
Loading ...

Biogen Inc - Stoke Retains Exclusive Rights for Zorevunersen in US, Canada, Mexico; Biogen Gets Rest of World

THOMSON REUTERS
·
18 Feb

Biogen and Stoke Therapeutics Enter Into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated With Refractory Seizures and Neurodevelopmental Impairments

THOMSON REUTERS
·
18 Feb

Biogen Inc - Stoke to Receive $165M Upfront, up to $385M in Milestones

THOMSON REUTERS
·
18 Feb

Guggenheim Cuts Biogen Price Target to $168 From $190

MT Newswires Live
·
15 Feb

Biogen (BIIB) Receives a Buy from Evercore ISI

TIPRANKS
·
14 Feb

Biogen’s Growth Potential Amidst Challenges: A Buy Rating by Marc Goodman

TIPRANKS
·
14 Feb

Biogen’s Earnings Call Highlights: New Product Success Amid MS Declines

TIPRANKS
·
14 Feb

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
14 Feb

Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts

Benzinga
·
14 Feb

Biogen Still Offering Value, RBC Says

MT Newswires Live
·
14 Feb

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance

Zacks
·
14 Feb

Biogen price target lowered to $224 from $244 at Scotiabank

TIPRANKS
·
13 Feb

Piper Sandler Remains a Hold on Biogen (BIIB)

TIPRANKS
·
13 Feb

Biogen price target lowered to $139 from $156 at BMO Capital

TIPRANKS
·
13 Feb

Biogen Analysts Lower Their Forecasts After Q4 Results

Benzinga
·
13 Feb

Biogen Is Maintained at Buy by Truist Securities

Dow Jones
·
13 Feb

Biogen price target lowered to $241 from $300 at H.C. Wainwright

TIPRANKS
·
13 Feb

Biogen : Bmo Cuts Target Price to $139 From $156

THOMSON REUTERS
·
13 Feb

BUZZ-Street View: Analysts optimistic on Biogen's Alzheimer's disease drug

Reuters
·
13 Feb

Biogen Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
13 Feb